Abstract: Apparatus and method for coverage hole detection in a wireless local area network (WLAN) using a mobile communication device. The method includes a first step of providing a plurality of access points distributed within the WLAN and at least one mobile communication device operable within the WLAN. A next step includes downloading triggers for respective coverage measurement conditions to the at least one associated mobile communication device from an associated access point. A next step includes detecting a coverage measurement condition by the at least one mobile communication device that activates one of the triggers, whereupon a next step includes sending a coverage measurement indicating the triggered condition from the at least one mobile communication device to an associated access point, which forwards a coverage incident report to a Central Report Manager.

Abstract: The present invention provides crystalline Forms FUM-P3, FUM-P4, MLA-P3 and MLA-P4 of compound formula 1 and related methods of treating and/or preventing a disease, such as a central nervous system disease (e.g., an anxiety disorder), using a crystalline Form FUM-P3, FUM-P4, MLA-P3 and MLA-P4 of compound formula 1 and/or pharmaceutical compositions thereof.

Abstract: Apparatus and method for coverage hole detection in a wireless local area network (WLAN) using a mobile communication device. The method includes a first step of providing a plurality of access points distributed within the WLAN and at least one mobile communication device operable within the WLAN. A next step includes downloading triggers for respective coverage measurement conditions to the at least one associated mobile communication device from an associated access point. A next step includes detecting a coverage measurement condition by the at least one mobile communication device that activates one of the triggers, whereupon a next step includes sending a coverage measurement indicating the triggered condition from the at least one mobile communication device to an associated access point, which forwards a coverage incident report to a Central Report Manager.

Abstract: Apparatus and method for coverage hole detection in a wireless local area network (WLAN) using a mobile communication device. The method includes a first step of providing a plurality of access points distributed within the WLAN and at least one mobile communication device operable within the WLAN. A next step includes downloading triggers for respective coverage measurement conditions to the at least one associated mobile communication device from an associated access point. A next step includes detecting a coverage measurement condition by the at least one mobile communication device that activates one of the triggers, whereupon a next step includes sending a coverage measurement indicating the triggered condition from the at least one mobile communication device to an associated access point, which forwards a coverage incident report to a Central Report Manager.

Abstract: The present invention provides crystalline Forms FUM-P3, FUM-P4, MLA-P3 and MLA-P4 of compound formula 1 and related methods of treating and/or preventing a disease, such as a central nervous system disease (e.g., an anxiety disorder), using a crystalline Form FUM-P3, FUM-P4, MLA-P3 and MLA-P4 of compound formula 1 and/or pharmaceutical compositions thereof.

Abstract: The present invention provides amorphous arid crystalline forms of 1-ethyl-6-(indan-2-ylamino)-3-(morpholine-4-carbonyl)-1,8-naphthyridin-4-one (compound 1), and salts, co-crystals, and pharmaceutical compositions thereof. The invention also provides methods of treating and/or preventing a disease, such as a central nervous system disease (e.g., an anxiety disorder), using the amorphous and crystalline forms, and salts, co-crystals, and pharmaceutical compositions thereof.

Abstract: Apparatus and method for coverage hole detection in a wireless local area network (WLAN) using a mobile communication device. The method includes a first step of providing a plurality of access points distributed within the WLAN and at least one mobile communication device operable within the WLAN. A next step includes downloading triggers for respective coverage measurement conditions to the at least one associated mobile communication device from an associated access point. A next step includes detecting a coverage measurement condition by the at least one mobile communication device that activates one of the triggers, whereupon a next step includes sending a coverage measurement indicating the triggered condition from the at least one mobile communication device to an associated access point, which forwards a coverage incident report to a Central Report Manager.

Abstract: The present invention provides amorphous arid crystalline forms of 1-ethyl-6-(indan-2-ylamino)-3-(morpholine-4-carbonyl)-1,8-naphthyridin-4-one (compound 1), and salts, co-crystals, and pharmaceutical compositions thereof. The invention also provides methods of treating and/or preventing a disease, such as a central nervous system disease (e.g., an anxiety disorder), using the amorphous and crystalline forms, and salts, co-crystals, and pharmaceutical compositions thereof.